Clinical trial
A Continued Access Study to Evaluate Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions
NCT03998657 is registered in ClinicalTrials.gov with InSightec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Continued Access Study to Evaluate Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions
- Lead sponsor
- InSightec
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 19, 2019
- Completion date
- December 30, 2026
- Enrollment
- 14 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer